Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 9
Original Research
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,652 | Dovepress* | 8,374+ | 1,678 | 10,052 | |
| PubMed Central* | 1,278 | 587 | 1,865 | ||
| Totals | 9,652 | 2,265 | 11,917 | ||
| *Since 25 October 2017 | |||||
View citations on PubMed Central and Google Scholar